Kungl. Vetenskapsakademien - The First Sj÷berg Prize, Totalling 1 Million US Dollars, is Awarded for Discoveries That Have Led to New and Effective Cancer Treatments

Tuesday, February 14, 2017 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

BOX, Sweden, Feb 14, 2017 /PRNewswire/ --

The Royal Swedish Academy

of Sciences has decided to award the Sj÷berg Prize 2017 to James P. Allison, The University of Texas MD Anderson Cancer Center, Houston,
, USA and
Tony Hunter, Salk Institute for Biological Studies, La Jolla, CA, USA "for groundbreaking studies of cellular processes that have led to the development of new and effective cancer drugs"

The Sj÷berg Prize is an annual international prize in cancer research that is now being awarded for the first time. The prize is financed by the Sj÷berg Foundation, and the Royal Swedish Academy of Sciences is responsible for selecting the Laureates. The foundation was founded in 2016 by the late businessman Bengt Sj÷berg, who donated 2 billion Swedish krona, one of the biggest donations in Swedish history.

"We are delighted that we can encourage future cancer research by awarding this prize to two such outstanding researchers. Their discoveries have led to improved cancer treatment for thousands of people and we are proud to be awarding them the first Sj÷berg Prize. Their high-quality research represents the Sj÷berg Foundation's idea and purpose of inspiring and aiding new efforts in the work to fight cancer," says the donor's brother, Ingemar Sj÷berg, Chairman of the Sj÷berg Foundation.

The prize totals 1 million US dollars and is shared equally between the Laureates. It is divided into a personal award of 100,000 US dollars and a grant for future research of 900,000 US dollars.

This year, the research being rewarded has opened up two entirely new ways of treating cancer.

James Allison investigated how the white blood cells known as T cells are activated, and how a specific "brake" signal could be prevented. He realised that when this brake is removed, the immune system can use its full potential to attack tumour cells. These discoveries have resulted in the cancer pharmaceuticals that are called immune checkpoint inhibitors and which are of decisive significance in treating melanoma. They are also used in treating other forms of cancer and numerous clinical trials are underway.

"I am honored and humbled to be a recipient of the first Sj÷berg Prize, and feel that it acknowledges the effort of all those who worked to translate fundamental understanding of immunological processes into treatment strategies that are saving the lives of many cancer patients," says James Allison.

James P. Allison was born in 1948 in Alice, Texas, USA. He is professor and Vivian L. Smith Distinguished Chair in Immunology at The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Tony Hunter studied how normal cells become tumour cells, demonstrating that a special process was necessary: tyrosine phosphorylation. His discovery led to the development of a new type of cancer pharmaceutical, tyrosine kinase inhibitors. These have revolutionised the treatment of chronic myeloid leukaemia (KML) and are also of great benefit in other forms of cancer.á

"I am deeply honoured to have been recognized by the inaugural Sj÷berg Prize. It is very gratifying that our work on a simple chicken tumour virus has ultimately led to new and effective therapies for human cancer, with 26 tyrosine kinase inhibitor drugs currently approved for clinical use," says Tony Hunter.

Tony Hunter was born in 1943 in Ashford, Kent in the United Kingdom. He is an American Cancer Society Professor and Renato Dulbecco Chair, and Deputy Director of the Salk Institute Cancer Center at the Salk Institute for Biological Studies, La Jolla, California, USA. á

The award ceremony will be during the Royal Swedish Academy of Sciences' Annual Meeting on 31 March 2017 in the presence of His Majesty the King and Her Majesty the Queen of Sweden. The laureates will hold open lectures at Karolinska Institutet on 30 March.

Further information, press photos and illustrations for editorial use are available at:




Bengt Westermark, Chairman of the prize committeeProfessor of Tumor Biology+46-70-818-18-44bengt.westermark@igp.uu.se

Rune Toftgňrd, Secretary of the prize committeeProfessor of Environmental Toxicology+46-8-673-95-60rune.toftgard@kva.se

The Sj÷berg FoundationIngemar Sj÷berg, Chairman of the Sj÷berg Foundation+46-70-799-14-79info@sjobergstiftelsen.se

Press contact:

Fredrik All, Head of Communications and Press,á+46-8-673-95-63,á+46-70-673-95-63, fredrik.all@kva.se á

This information was brought to you by Cision http://news.cision.comhttp://news.cision.com/kungl--vetenskapsakademien/r/the-first-sjoberg-prize--totalling-1-million-us-dollars--is-awarded-for-discoveries-that-have-led-to,c2166287


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kungl-vetenskapsakademien---the-first-sjoberg-prize-totalling-1-million-us-dollars-is-awarded-for-discoveries-that-have-led-to-new-and-effective-cancer-treatments-300406835.html

SOURCE Kungl. Vetenskapsakademien


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store